pharma news

News

First-quarter sales strength buoys new GSK CEO Miels

GSK has had a solid start to 2026, with revenues rising ahead of analyst expectations in the first full quarter under new CEO Luke Miels.

News

UK study finds clue to rising cancer rates in younger people

A study has found evidence that 11 cancers are becoming more common among young people in England, and points to a main driving factor.

News

Merck partners Remepy in PDURS-focused alliance

Merck KGaA has started working with Remepy on the development of hybrid drugs that combine medicines with digital therapeutics.

News

Can Purdue finally get its bankruptcy plan over the line?

OxyContin manufacturer Purdue is on the brink of a bankruptcy deal that could put years of opioid liability litigation in its rearview mirror.

News

Eli Lilly + Profluent typed in white font on black background

AI start-up Profluent nabs Lilly as first big pharma partner

AI start-up Profluent has signed a major alliance with pharma group Eli Lilly, worth up to $2.25bn, that will focus on gene-editing therapies.

News

GSK eyes October FDA verdict on chronic hep B drug

GSK's antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, has started a speedy FDA review that should deliver a verdict by 26th October.

First-quarter sales strength buoys new GSK CEO Miels

UK study finds clue to rising cancer rates in younger people

Merck partners Remepy in PDURS-focused alliance

Can Purdue finally get its bankruptcy plan over the line?

AI start-up Profluent nabs Lilly as first big pharma partner

GSK eyes October FDA verdict on chronic hep B drug

Blackstone buys into Pfizer's GLP-1 drug development

Securing your ROI: Turning post-acquisition integration into...

pharma news

Editor's Picks